United States Healthcare Equipment & Supplies

Envoy Medical Inc (COCH)

Track

Track

Envoy Medical Inc experienced significant insider buying on February 12, 2026. Multiple individuals, including the Chief Executive Officer and Interim CFO, acquired shares totaling substantial value. This activity represents the most recent recorded transactions for the firm, occurring well beyond the three-month window, indicating a period of notable accumulation by key stakeholders.
Ticker: COCH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Envoy Medical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Patel Mona Chetan Non-Executive Director
Transaction date
Purchase
Price
77.28
Quantity 19,396 -17.7%
Value US$4,873,046
2.4
BRYNELSEN CHARLES Non-Executive Director
Transaction date
Purchase
Price
176.45
Quantity 88,232 +22.2%
Value US$3,853,737
Potashnick Robert Interim CFO Officer
Transaction date
Purchase
Price
136.87
Quantity 46,399 +3.1%
Value US$3,081,767
0.9
Kantor Susan Non-Executive Director
Transaction date
Purchase
Price
0.40
Quantity 96,150 +123.4%
Value US$38,460
3.3
Lucas Brent T. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.40
Quantity 62,500 +26.6%
Value US$25,000
TAYLOR GLEN A Large shareholder
Transaction date
Purchase
Price
0.40
Quantity 18,750,000 +634.8%
Value US$7,500,000
1.6
Patel Mona Chetan Non-Executive Director
Transaction date
Purchase
Price
1.47
Quantity 2,500 +14.3%
Value US$3,675
1.6
Patel Mona Chetan Non-Executive Director
Transaction date
Purchase
Price
1.46
Quantity 10,000 +133.3%
Value US$14,600
2.4
BRYNELSEN CHARLES Non-Executive Director
Transaction date
Purchase
Price
1.65
Quantity 35,000 +233.3%
Value US$57,673
2.4
BRYNELSEN CHARLES Non-Executive Director
Transaction date
Purchase
Price
1.64
Quantity 13,000 +650.0%
Value US$21,363
2.4
BRYNELSEN CHARLES Non-Executive Director
Transaction date
Purchase
Price
1.68
Quantity 2,000 +inf%
Value US$3,367
1.6
Patel Mona Chetan Non-Executive Director
Transaction date
Purchase
Price
2.28
Quantity 2,500 +50.0%
Value US$5,699
1.6
Patel Mona Chetan Non-Executive Director
Transaction date
Purchase
Price
3.33
Quantity 4,000 +400.0%
Value US$13,320
1.6
Patel Mona Chetan Non-Executive Director
Transaction date
Purchase
Price
3.20
Quantity 1,000 +inf%
Value US$3,200
3.3
Lucas Brent T. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.92
Quantity 2,380 +2.0%
Value US$2,190
3.3
Lucas Brent T. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.98
Quantity 10,000 +9.2%
Value US$9,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-17 2026-02-12 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
19,396 -17.7%
77.28
US$4,873,046 		19,396 -17.7% 77.28 US$4,873,046
2026-02-17 2026-02-12 B Purchase
2.4
BRYNELSEN CHARLES
Non-Executive Director
88,232 +22.2%
176.45
US$3,853,737 		88,232 +22.2% 176.45 US$3,853,737
2026-02-17 2026-02-12 B Purchase
Potashnick Robert

Interim CFO

Officer
46,399 +3.1%
136.87
US$3,081,767 		46,399 +3.1% 136.87 US$3,081,767
2026-02-17 2026-02-12 B Purchase
0.9
Kantor Susan
Non-Executive Director
96,150 +123.4%
0.40
US$38,460 		96,150 +123.4% 0.40 US$38,460
2026-02-17 2026-02-12 B Purchase
3.3
Lucas Brent T.

Chief Executive Officer

Executive Director
62,500 +26.6%
0.40
US$25,000 		62,500 +26.6% 0.40 US$25,000
2026-02-17 2026-02-12 B Purchase
TAYLOR GLEN A
Large shareholder
18,750,000 +634.8%
0.40
US$7,500,000 		18,750,000 +634.8% 0.40 US$7,500,000
2025-06-13 2025-06-11 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
2,500 +14.3%
1.47
US$3,675 		2,500 +14.3% 1.47 US$3,675
2025-06-10 2025-06-06 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
10,000 +133.3%
1.46
US$14,600 		10,000 +133.3% 1.46 US$14,600
2025-05-27 2025-05-27 B Purchase
2.4
BRYNELSEN CHARLES
Non-Executive Director
35,000 +233.3%
1.65
US$57,673 		35,000 +233.3% 1.65 US$57,673
2025-05-27 2025-05-23 B Purchase
2.4
BRYNELSEN CHARLES
Non-Executive Director
13,000 +650.0%
1.64
US$21,363 		13,000 +650.0% 1.64 US$21,363
2025-05-27 2025-05-22 B Purchase
2.4
BRYNELSEN CHARLES
Non-Executive Director
2,000 +inf%
1.68
US$3,367 		2,000 +inf% 1.68 US$3,367
2024-11-22 2024-11-20 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
2,500 +50.0%
2.28
US$5,699 		2,500 +50.0% 2.28 US$5,699
2024-09-11 2024-09-11 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
4,000 +400.0%
3.33
US$13,320 		4,000 +400.0% 3.33 US$13,320
2024-09-11 2024-09-09 B Purchase
1.6
Patel Mona Chetan
Non-Executive Director
1,000 +inf%
3.20
US$3,200 		1,000 +inf% 3.20 US$3,200
2023-11-24 2023-11-21 B Purchase
3.3
Lucas Brent T.

Chief Executive Officer

Executive Director
2,380 +2.0%
0.92
US$2,190 		2,380 +2.0% 0.92 US$2,190
2023-11-24 2023-11-21 B Purchase
3.3
Lucas Brent T.

Chief Executive Officer

Executive Director
10,000 +9.2%
0.98
US$9,800 		10,000 +9.2% 0.98 US$9,800
Explore more

More insider trading research around Envoy Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America